Identification of prevalent dementia in Medicare Advantage encounters, compared with rigorous cohort assessments
Identifikation prävalenter Demenz in Medicare-Advantage-Abrechnungsdaten im Vergleich zu robusten Kohorten-Begutachtungen
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 05.09.2026 · 81 (10)
DOI: 10.1093/gerona/glag206 ↗Auf einen Blick
In vier Kohortenstudien wurden Demenzindikatoren in Medicare-Advantage-(MA)-Daten gegen eine kognitive Standardbeurteilung validiert. Die MA-Diagnosen waren dafür insgesamt brauchbar.
Fragestellung
Wie valide sind Demenzdiagnosen in MA-Encounter-Daten im Vergleich zu einer rigorosen kognitiven Kohortenbeurteilung?
Methode
Validierungsstudie mit vier Kohortenstudien des Rush Alzheimer’s Disease Center und Medicare-Daten 2017–19; Vergleich von MA-Encounter-Indikatoren nach Bynum-Standard-Algorithmus mit Kohortenstatus; Replikation in Traditional Medicare.
Ergebnisse
Bei 508 MA-Versicherten hatten 62 (12 %) eine Demenz nach Kohortenbeurteilung. Nur mit Encounters: positiv prädiktiver Wert 63 % (95 %-KI 52–75 %), negativ prädiktiver Wert 96 % (95 %-KI 94–98 %), Genauigkeit 92 % (95 %-KI 89–94 %).
Einschränkungen
Sekundäranalyse zu MCI mit niedriger Sensitivität.
Schlussfolgerung der Autor:innen
Die auf dem Bynum-Standard-Algorithmus basierenden Indikatoren können ein valides Werkzeug zur Identifikation prävalenter Demenz sein und eignen sich für Forschung in MA; Unterschiede zu TM sprechen für mögliches Selektionsbias in MA-Plänen.
Kernaussagen
- 508 MA-Versicherte, 62 mit Demenz nach Kohortenbeurteilung
- PPV 63 %, NPV 96 %, Genauigkeit 92 %
- Bei MCI war die Sensitivität niedrig
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, online erschienen am 24.08.2026. Verfasst von Yi Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, United States. Hauptthemen laut MEDLINE: Dementia, Medicare Part C. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging.
Themen: Demenz
Abstract (Originalsprache)
Background
Rapid growth in Medicare Advantage (MA) enrollment has spurred dementia research using diagnoses in MA encounter data. However, the validity of MA-encounter-based dementia diagnoses is uncertain.
Methods
Using four cohort studies at the Rush Alzheimer’s Disease Center linked to Medicare data from 2017–19, we validated prevalent dementia indicators in MA encounter data, based on the Bynum-Standard algorithm, against dementia status determined by rigorous cognitive assessment in the cohort studies. We replicated analyses among participants in Traditional Medicare (TM).
Results
Of the 508 eligible MA enrollees, mean age was 82.8 (SD = 7.2) years, 81% were female, and 49% were non-Latino White; 62 participants (12%) were classified as having dementia by the cohort assessment. MA-encounter-based dementia indicators performed reasonably well in identifying participants with cohort-assessed dementia: using encounters alone, positive predictive value was 63% (95% CI: 52%-75%), negative predictive value was 96% (95% CI: 94%-98%), and accuracy was 92% (95% CI: 89%-94%). Inclusion of chart reviews did not impact performance. Compared to TM-based indicators during the same period, MA-based indicators yielded similar validity metrics but identified a less functionally impaired group as having dementia. In secondary validation analysis of mild cognitive impairment (MCI), sensitivity was low.
Conclusions
As one of the first studies to validate dementia diagnoses in MA encounter data, indicators based on the Bynum-Standard algorithm can be a valid tool for identifying prevalent dementia. Findings support the use of MA-encounter-based dementia indicators for research within MA. However, observed health differences between MA- and TM-identified dementia groups suggest potential for selection bias in MA plans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, United States.
- Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, United States.
- Department of Internal Medicine, School of Medicine, University of Michigan, Ann Arbor, Michigan, United States.
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan, United States.
- Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan, United States.
ORCID-Profile: Yi Chen, Bryan D James
Förderung
- NIA NIH HHS
- National Institute on Aging
Zitieren
APA
Chen, Y., Benloucif, S., James, B. D., Banerjee, M., Grodstein, F., & Bynum, J. P. W. (2026). Identification of prevalent dementia in Medicare Advantage encounters, compared with rigorous cohort assessments. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 81(10). https://doi.org/10.1093/gerona/glag206
Vancouver
Chen Y, Benloucif S, James BD, Banerjee M, Grodstein F, Bynum JPW. Identification of prevalent dementia in Medicare Advantage encounters, compared with rigorous cohort assessments. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2026;81(10). doi:10.1093/gerona/glag206
BibTeX
@article{Chen2026,
author = {Chen, Yi and Benloucif, Slim and James, Bryan D and Banerjee, Mousumi and Grodstein, Francine and Bynum, Julie P W},
title = {Identification of prevalent dementia in Medicare Advantage encounters, compared with rigorous cohort assessments},
journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
year = {2026},
volume = {81},
number = {10},
doi = {10.1093/gerona/glag206}
}
EUVIMED